Madrigal Pharmaceuticals (MDGL) Total Debt (QoQ) (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) Total Debt (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Madrigal Pharmaceuticals | 15.79 Bn | 15.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13% |
| Dec 31, 2025 | 0.04% |
| Sep 30, 2025 | 187.01% |
| Jun 30, 2025 | 0.31% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | 0.41% |
| Sep 30, 2024 | 0.41% |
| Jun 30, 2024 | 0.41% |
| Mar 31, 2024 | 0.57% |
| Dec 31, 2023 | -22.44% |
| Sep 30, 2023 | 50.02% |
| Jun 30, 2023 | -12.71% |
| Mar 31, 2023 | 130.67% |
| Dec 31, 2022 | 0.62% |
| Sep 30, 2022 | 0.64% |
| Jun 30, 2016 | -99.57% |
| Mar 31, 2016 | -50.10% |
| Dec 31, 2015 | -33.36% |
| Sep 30, 2015 | -25.00% |
| Jun 30, 2015 | -19.99% |